Beike Biotech

Articles

Clinical Studies

Clinical Studies

Below is a list of our clinical studies either completed, ongoing, or planned. Those listed as "clinical studies" are meant to have accompanying publications submitted for publications in international journals. 

Condition

Type of Cells

# of Subjects

Duration

Location

Start Date

End Date

Clinical study

 

SLE

UC-MSC

96

18 Months

China/multiple sites

09/2009

03/2011

MS

UC-MSC

96

24 Months

China/multiple sites

09/2009

09/2011

LC

UC-MSC/BM-MSC

72

24 Months

China/multiple sites

12/2009

12/2011

SCA

UC-MSC

36

12 Months

China/multiple sites

10/2009

10/2010

Autism

UCB-MNC

48

12 Months

Jinan,China/single site

03/2009

03/2010

DMD

UC-MSC

48

12 Months

Shenyang,China/single site

06/2009

06/2010

DF

PBSC

36

12 Months

Dehhi, India / single site

10/2009

10/2010

Experimental therapy

 

DF

BM-MNC

40

24 Months

Shenyang,China/single site

10/2006

10/2008

SCI

BM-MSC

48

24 Months

Shenyang,China/single site

10/2006

10/2008

ONH

UCB-MNC

24

24 Months

Qingdao,China/single site

09/2009

09/2011

CP

UCB-MNC

60

12 Months

Beijing,China/single site

01/2008

12/2008

 

UCB-MNC=umbilical cord blood mononuclear cells; UC-MSC=umbilical cord mesenchymal stem cells; BM-MSC=bone marrow mesenchymal stem cells; BM-MNC=bone marrow mononuclear cells; PBSC=peripheral blood stem cells;  SLE=Systemic lupus erythematosus; MS=Multiple sclerosis; SCA=Spinocerebellar ataxia; ONH=optic nerve hypoplasia; DMD=Duchenne muscular dystrophy; DF=Diabetic foot; SCI=Spinal cord injury; CP=Cerebral palsy